Michael O’Donovan

De novo mutations in schizophrenia implicate synaptic networks

Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls

There is increasing evidence that genome-wide association (GWA) studies represent a powerful approach to the identification of genes involved in common human diseases. We descri...

The contribution of rare variants to risk of schizophrenia in individuals with and without intellectual disability

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes

Common polygenic variation contributes to risk of schizophrenia and bipolar disorder

Genome-wide association analysis identifies 13 new risk loci for schizophrenia

Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder

Genetic architectures of psychiatric disorders: the emerging picture and its implications

Identification of loci associated with schizophrenia by genome-wide association and follow-up

Genome-wide significant associations in schizophrenia to ITIH3/4, CACNA1C and SDCCAG8, and extensive replication of associations reported by the Schizophrenia PGC

Common variants at VRK2 and TCF4 conferring risk of schizophrenia

Common sequence variants have recently joined rare structural polymorphisms as genetic factors with strong evidence for association with schizophrenia. Here we extend our previo...

Genome-Wide Association Study of Schizophrenia in a Japanese Population

Genome-Wide Association Study Implicates HLA-C*01:02 as a Risk Factor at the Major Histocompatibility Complex Locus in Schizophrenia

Association between genetic variation in a region on chromosome 11 and schizophrenia in large samples from Europe